Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data.
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|
| _version_ | 1797092666216808448 |
|---|---|
| author | Barbui, C Cipriani, A Geddes, J |
| author_facet | Barbui, C Cipriani, A Geddes, J |
| author_sort | Barbui, C |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T03:49:17Z |
| format | Journal article |
| id | oxford-uuid:c0a78806-f679-4631-ae1a-a1ff9c1fe38a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:49:17Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:c0a78806-f679-4631-ae1a-a1ff9c1fe38a2022-03-27T05:55:55ZAntidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c0a78806-f679-4631-ae1a-a1ff9c1fe38aEnglishSymplectic Elements at Oxford2008Barbui, CCipriani, AGeddes, J |
| spellingShingle | Barbui, C Cipriani, A Geddes, J Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. |
| title | Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. |
| title_full | Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. |
| title_fullStr | Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. |
| title_full_unstemmed | Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. |
| title_short | Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. |
| title_sort | antidepressants and suicide symptoms compelling new insights from the fda s analysis of individual patient level data |
| work_keys_str_mv | AT barbuic antidepressantsandsuicidesymptomscompellingnewinsightsfromthefdasanalysisofindividualpatientleveldata AT cipriania antidepressantsandsuicidesymptomscompellingnewinsightsfromthefdasanalysisofindividualpatientleveldata AT geddesj antidepressantsandsuicidesymptomscompellingnewinsightsfromthefdasanalysisofindividualpatientleveldata |